I decided to give you a feature about a very solid pharmaceutical company, and why they are primed for continued growth. I always love a company that is willing to put their profits back into research for continued product growth and share price growth. A great company with a great chart.

According to the National Osteoporosis Foundation, osteoporosis afflicts approximately 10 million Americans; approximately 34 million individuals have low bone mass, putting them at risk for osteoporosis. Unigene Laboratories Inc. (OTCBB: UGNE) is a biopharmaceutical company engaged in the oral and nasal administration of large-market peptide drugs.

Demographic trends and the persistence of medical afflictions should continue to drive revenue growth for healthcare providers, and the non-discretionary nature of their products limits volatility. This article examines some of the sub-industries within healthcare and their potential to provide good investments.